US Stock MarketDetailed Quotes

CYBN Cybin

Watchlist

10.3800
+0.1300+1.27%

Close Nov 29 13:00 ET

10.7100
+0.3300+3.18%

Post 16:50 ET

207.52MMarket Cap-1701P/E (TTM)

Cybin Stock Forum

Mr Trecherous

Nov 25 20:06

Get Healthy 💪🏼 🥑 🥥 🍄 🐮

$Trump Media & Technology (DJT.US)$ $Pfizer (PFE.US)$ $McDonald's (MCD.US)$ $Tesla (TSLA.US)$ $AMC Entertainment (AMC.US)$ $Cybin (CYBN.US)$

Moo Humor

EZ_money

Nov 21 10:30

$Cybin (CYBN.US)$ buying more now 🖕

EZ_money

Nov 19 07:44

$Cybin (CYBN.US)$👀 more news out on trials 100% effectiveness so far on the therapy drug for treating depression
CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
trading under 12 now seems like something is in the works.
$Vertex Pharmaceuticals (VRTX.US)$ $Astera Labs (ALAB.US)$ $Emergent BioSolutions (EBS.US)$

EZ_money

Nov 18 14:05

$Cybin (CYBN.US)$ break the downward wedge LFG 🐂💥🚀

EZ_money

Nov 18 11:50

$Cybin (CYBN.US)$ say what ??? 🤣
$NVIDIA (NVDA.US)$ $Tesla (TSLA.US)$ $SoFi Technologies (SOFI.US)$

EZ_money

Nov 18 11:48

$Cybin (CYBN.US)$ i suppose the good news is reason to sell

Jaguar8

Nov 18 08:19

NEWS

$Cybin (CYBN.US)$
Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder
Cybin Inc. (NYSE American:CYBN)reported groundbreaking 12-month efficacy data from its Phase 2 study of CYB003 for major depressive disorder (MDD). After two 16mg doses administered three weeks apart, 100% of participants were responsive to treatment, with 71% in remission at 12 months. The study showed a ~23-point reduction in MADRS depression s...